H
Hinova Pharmaceuticals Inc
SSE:688302
Hinova Pharmaceuticals Inc
SSE:688302
Price:
41.4
CNY
-0.72%
Market Closed
Market Cap:
¥4.1B
Cash Flow Statement
Cash Flow Statement
Hinova Pharmaceuticals Inc
Hinova Pharmaceuticals Inc
Currency: CNY
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||
| Stock-Based Compensation |
109
|
0
|
0
|
0
|
103
|
0
|
0
|
76
|
0
|
0
|
0
|
25
|
0
|
0
|
|
| Cash Taxes Paid |
6
|
4
|
10
|
6
|
13
|
13
|
17
|
19
|
19
|
19
|
10
|
(0)
|
(1)
|
(1)
|
|
| Change in Working Capital |
(234)
|
(269)
|
(305)
|
(300)
|
(329)
|
(321)
|
(342)
|
(275)
|
(272)
|
(310)
|
(205)
|
(187)
|
(161)
|
(145)
|
|
| Cash from Operating Activities |
(228)
N/A
|
(265)
-16%
|
(295)
-11%
|
(294)
+0%
|
(315)
-7%
|
(306)
+3%
|
(324)
-6%
|
(256)
+21%
|
(252)
+1%
|
(291)
-15%
|
(195)
+33%
|
(187)
+4%
|
(162)
+14%
|
(135)
+16%
|
|
| Investing Cash Flow | |||||||||||||||
| Capital Expenditures |
(20)
|
(34)
|
(39)
|
(51)
|
(69)
|
(74)
|
(111)
|
(99)
|
(105)
|
(157)
|
(132)
|
(90)
|
(89)
|
(52)
|
|
| Other Items |
23
|
997
|
(328)
|
(1 395)
|
(341)
|
(668)
|
876
|
(0)
|
(118)
|
180
|
64
|
59
|
148
|
222
|
|
| Cash from Investing Activities |
3
N/A
|
963
+28 008%
|
(367)
N/A
|
(1 446)
-294%
|
(410)
+72%
|
(742)
-81%
|
765
N/A
|
(99)
N/A
|
(223)
-125%
|
23
N/A
|
(68)
N/A
|
(30)
+56%
|
58
N/A
|
170
+191%
|
|
| Financing Cash Flow | |||||||||||||||
| Net Issuance of Debt |
(1)
|
0
|
0
|
0
|
30
|
0
|
30
|
(30)
|
0
|
0
|
0
|
0
|
0
|
100
|
|
| Cash Paid for Dividends |
0
|
0
|
(2)
|
(3)
|
(4)
|
(4)
|
(2)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
|
| Other |
(8)
|
(12)
|
988
|
988
|
991
|
995
|
(4)
|
(4)
|
(4)
|
(5)
|
(4)
|
(4)
|
(5)
|
(4)
|
|
| Cash from Financing Activities |
(8)
N/A
|
(12)
-47%
|
986
N/A
|
985
0%
|
1 017
+3%
|
1 021
+0%
|
24
-98%
|
(35)
N/A
|
(35)
+2%
|
(35)
-3%
|
(34)
+4%
|
(4)
+88%
|
(4)
-10%
|
96
N/A
|
|
| Change in Cash | |||||||||||||||
| Effect of Foreign Exchange Rates |
(2)
|
(3)
|
4
|
8
|
8
|
7
|
1
|
2
|
3
|
4
|
(2)
|
1
|
1
|
1
|
|
| Net Change in Cash |
(235)
N/A
|
682
N/A
|
327
-52%
|
(746)
N/A
|
300
N/A
|
(21)
N/A
|
465
N/A
|
(388)
N/A
|
(507)
-31%
|
(299)
+41%
|
(300)
0%
|
(220)
+27%
|
(107)
+52%
|
131
N/A
|
|
| Free Cash Flow | |||||||||||||||
| Free Cash Flow |
(248)
N/A
|
(300)
-21%
|
(334)
-12%
|
(345)
-3%
|
(384)
-11%
|
(381)
+1%
|
(435)
-14%
|
(355)
+19%
|
(357)
-1%
|
(448)
-25%
|
(327)
+27%
|
(277)
+15%
|
(251)
+9%
|
(188)
+25%
|
|
Switch to:
Switch to:
See Also
Discover More
